D. Leenaerts

Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis

J. Aernouts, A. Lambeir, P. Van der Veken, 2017, Thrombosis and Haemostasis.

Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke

J. Michel, J. Desilles, M. Mazighi, 2020, Journal of thrombosis and haemostasis : JTH.

Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

J. Mertens, D. Hendriks, D. Leenaerts, 2021, International journal of molecular sciences.

Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis

A. Lambeir, J. Mertens, D. Hendriks, 2019, Journal of thrombosis and haemostasis : JTH.

Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction

A. Lambeir, J. Bosmans, P. Veken, 2015, Journal of thrombosis and haemostasis : JTH.

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin‐activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models

J. Michel, A. Lambeir, J. Mertens, 2018, Journal of thrombosis and haemostasis : JTH.

Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood–brain barrier dysfunction

A. Lambeir, R. Brouns, M. Ieven, 2018, Journal of thrombosis and haemostasis : JTH.